Report Detail

Pharma & Healthcare Global Purinergic Receptor Antagonists Market Growth (Status and Outlook) 2022-2028

  • RnM4439181
  • |
  • 12 May, 2022
  • |
  • Global
  • |
  • 103 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Purinergic Receptor Antagonists Market Size 2017-2028
    • 2.1.2 Purinergic Receptor Antagonists Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Purinergic Receptor Antagonists Segment by Receptor Type
    • 2.2.1 P2Y
    • 2.2.2 P2X
  • 2.3 Purinergic Receptor Antagonists Market Size by Receptor Type
    • 2.3.1 Purinergic Receptor Antagonists Market Size CAGR by Receptor Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Purinergic Receptor Antagonists Market Size Market Share by Receptor Type (2017-2022)
  • 2.4 Purinergic Receptor Antagonists Segment by Application
    • 2.4.1 Heart Disease
    • 2.4.2 Stroke
    • 2.4.3 Others
  • 2.5 Purinergic Receptor Antagonists Market Size by Application
    • 2.5.1 Purinergic Receptor Antagonists Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Purinergic Receptor Antagonists Market Size Market Share by Application (2017-2022)

3 Purinergic Receptor Antagonists Market Size by Player

  • 3.1 Purinergic Receptor Antagonists Market Size Market Share by Players
    • 3.1.1 Global Purinergic Receptor Antagonists Revenue by Players (2020-2022)
    • 3.1.2 Global Purinergic Receptor Antagonists Revenue Market Share by Players (2020-2022)
  • 3.2 Global Purinergic Receptor Antagonists Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Purinergic Receptor Antagonists by Regions

  • 4.1 Purinergic Receptor Antagonists Market Size by Regions (2017-2022)
  • 4.2 Americas Purinergic Receptor Antagonists Market Size Growth (2017-2022)
  • 4.3 APAC Purinergic Receptor Antagonists Market Size Growth (2017-2022)
  • 4.4 Europe Purinergic Receptor Antagonists Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Purinergic Receptor Antagonists Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Purinergic Receptor Antagonists Market Size by Country (2017-2022)
  • 5.2 Americas Purinergic Receptor Antagonists Market Size by Receptor Type (2017-2022)
  • 5.3 Americas Purinergic Receptor Antagonists Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Purinergic Receptor Antagonists Market Size by Region (2017-2022)
  • 6.2 APAC Purinergic Receptor Antagonists Market Size by Receptor Type (2017-2022)
  • 6.3 APAC Purinergic Receptor Antagonists Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Purinergic Receptor Antagonists by Country (2017-2022)
  • 7.2 Europe Purinergic Receptor Antagonists Market Size by Receptor Type (2017-2022)
  • 7.3 Europe Purinergic Receptor Antagonists Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Purinergic Receptor Antagonists by Region (2017-2022)
  • 8.2 Middle East & Africa Purinergic Receptor Antagonists Market Size by Receptor Type (2017-2022)
  • 8.3 Middle East & Africa Purinergic Receptor Antagonists Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Purinergic Receptor Antagonists Market Forecast

  • 10.1 Global Purinergic Receptor Antagonists Forecast by Regions (2023-2028)
    • 10.1.1 Global Purinergic Receptor Antagonists Forecast by Regions (2023-2028)
    • 10.1.2 Americas Purinergic Receptor Antagonists Forecast
    • 10.1.3 APAC Purinergic Receptor Antagonists Forecast
    • 10.1.4 Europe Purinergic Receptor Antagonists Forecast
    • 10.1.5 Middle East & Africa Purinergic Receptor Antagonists Forecast
  • 10.2 Americas Purinergic Receptor Antagonists Forecast by Country (2023-2028)
    • 10.2.1 United States Purinergic Receptor Antagonists Market Forecast
    • 10.2.2 Canada Purinergic Receptor Antagonists Market Forecast
    • 10.2.3 Mexico Purinergic Receptor Antagonists Market Forecast
    • 10.2.4 Brazil Purinergic Receptor Antagonists Market Forecast
  • 10.3 APAC Purinergic Receptor Antagonists Forecast by Region (2023-2028)
    • 10.3.1 China Purinergic Receptor Antagonists Market Forecast
    • 10.3.2 Japan Purinergic Receptor Antagonists Market Forecast
    • 10.3.3 Korea Purinergic Receptor Antagonists Market Forecast
    • 10.3.4 Southeast Asia Purinergic Receptor Antagonists Market Forecast
    • 10.3.5 India Purinergic Receptor Antagonists Market Forecast
    • 10.3.6 Australia Purinergic Receptor Antagonists Market Forecast
  • 10.4 Europe Purinergic Receptor Antagonists Forecast by Country (2023-2028)
    • 10.4.1 Germany Purinergic Receptor Antagonists Market Forecast
    • 10.4.2 France Purinergic Receptor Antagonists Market Forecast
    • 10.4.3 UK Purinergic Receptor Antagonists Market Forecast
    • 10.4.4 Italy Purinergic Receptor Antagonists Market Forecast
    • 10.4.5 Russia Purinergic Receptor Antagonists Market Forecast
  • 10.5 Middle East & Africa Purinergic Receptor Antagonists Forecast by Region (2023-2028)
    • 10.5.1 Egypt Purinergic Receptor Antagonists Market Forecast
    • 10.5.2 South Africa Purinergic Receptor Antagonists Market Forecast
    • 10.5.3 Israel Purinergic Receptor Antagonists Market Forecast
    • 10.5.4 Turkey Purinergic Receptor Antagonists Market Forecast
    • 10.5.5 GCC Countries Purinergic Receptor Antagonists Market Forecast
  • 10.6 Global Purinergic Receptor Antagonists Forecast by Receptor Type (2023-2028)
  • 10.7 Global Purinergic Receptor Antagonists Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Sanofi
    • 11.1.1 Sanofi Company Information
    • 11.1.2 Sanofi Purinergic Receptor Antagonists Product Offered
    • 11.1.3 Sanofi Purinergic Receptor Antagonists Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Sanofi Main Business Overview
    • 11.1.5 Sanofi Latest Developments
  • 11.2 Bristol Myers Squibb
    • 11.2.1 Bristol Myers Squibb Company Information
    • 11.2.2 Bristol Myers Squibb Purinergic Receptor Antagonists Product Offered
    • 11.2.3 Bristol Myers Squibb Purinergic Receptor Antagonists Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Bristol Myers Squibb Main Business Overview
    • 11.2.5 Bristol Myers Squibb Latest Developments
  • 11.3 Apotex
    • 11.3.1 Apotex Company Information
    • 11.3.2 Apotex Purinergic Receptor Antagonists Product Offered
    • 11.3.3 Apotex Purinergic Receptor Antagonists Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Apotex Main Business Overview
    • 11.3.5 Apotex Latest Developments
  • 11.4 Mylan
    • 11.4.1 Mylan Company Information
    • 11.4.2 Mylan Purinergic Receptor Antagonists Product Offered
    • 11.4.3 Mylan Purinergic Receptor Antagonists Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 Mylan Main Business Overview
    • 11.4.5 Mylan Latest Developments
  • 11.5 AstraZeneca
    • 11.5.1 AstraZeneca Company Information
    • 11.5.2 AstraZeneca Purinergic Receptor Antagonists Product Offered
    • 11.5.3 AstraZeneca Purinergic Receptor Antagonists Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 AstraZeneca Main Business Overview
    • 11.5.5 AstraZeneca Latest Developments
  • 11.6 Chiesi Farmaceutici
    • 11.6.1 Chiesi Farmaceutici Company Information
    • 11.6.2 Chiesi Farmaceutici Purinergic Receptor Antagonists Product Offered
    • 11.6.3 Chiesi Farmaceutici Purinergic Receptor Antagonists Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Chiesi Farmaceutici Main Business Overview
    • 11.6.5 Chiesi Farmaceutici Latest Developments
  • 11.7 Bayer
    • 11.7.1 Bayer Company Information
    • 11.7.2 Bayer Purinergic Receptor Antagonists Product Offered
    • 11.7.3 Bayer Purinergic Receptor Antagonists Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Bayer Main Business Overview
    • 11.7.5 Bayer Latest Developments
  • 11.8 Zydus Cadila Healthcare
    • 11.8.1 Zydus Cadila Healthcare Company Information
    • 11.8.2 Zydus Cadila Healthcare Purinergic Receptor Antagonists Product Offered
    • 11.8.3 Zydus Cadila Healthcare Purinergic Receptor Antagonists Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Zydus Cadila Healthcare Main Business Overview
    • 11.8.5 Zydus Cadila Healthcare Latest Developments
  • 11.9 Sun Pharmaceutical
    • 11.9.1 Sun Pharmaceutical Company Information
    • 11.9.2 Sun Pharmaceutical Purinergic Receptor Antagonists Product Offered
    • 11.9.3 Sun Pharmaceutical Purinergic Receptor Antagonists Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Sun Pharmaceutical Main Business Overview
    • 11.9.5 Sun Pharmaceutical Latest Developments
  • 11.10 Huahai Pharmaceutical
    • 11.10.1 Huahai Pharmaceutical Company Information
    • 11.10.2 Huahai Pharmaceutical Purinergic Receptor Antagonists Product Offered
    • 11.10.3 Huahai Pharmaceutical Purinergic Receptor Antagonists Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 Huahai Pharmaceutical Main Business Overview
    • 11.10.5 Huahai Pharmaceutical Latest Developments

12 Research Findings and Conclusion

As the global economy mends, the 2021 growth of Purinergic Receptor Antagonists will have significant change from previous year. According to our (LP Information) latest study, the global Purinergic Receptor Antagonists market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Purinergic Receptor Antagonists market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Purinergic Receptor Antagonists market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Purinergic Receptor Antagonists market, reaching US$ million by the year 2028. As for the Europe Purinergic Receptor Antagonists landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Purinergic Receptor Antagonists players cover Sanofi, Bristol Myers Squibb, Apotex, and Mylan, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Purinergic Receptor Antagonists market by product type, application, key players and key regions and countries.

Segmentation by receptor type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
P2Y
P2X

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Heart Disease
Stroke
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Sanofi
Bristol Myers Squibb
Apotex
Mylan
AstraZeneca
Chiesi Farmaceutici
Bayer
Zydus Cadila Healthcare
Sun Pharmaceutical
Huahai Pharmaceutical


Summary:
Get latest Market Research Reports on Purinergic Receptor Antagonists. Industry analysis & Market Report on Purinergic Receptor Antagonists is a syndicated market report, published as Global Purinergic Receptor Antagonists Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Purinergic Receptor Antagonists market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,650.00
$7,320.00
2,949.20
5,914.56
3,478.45
6,975.96
468,733.00
940,034.40
283,203.50
567,958.80
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report